Industries

The adoption of hemodynamic monitoring systems is growing in hospitals, driven by the development of advanced sensors for minimally invasive and noninvasive monitoring. Advancements in wearable and remote monitoring technologies are forecast to support adoption in out-of-hospital settings in the next decade. Vendors are increasingly investing in de...

The biopharma industry has been evolving over the past few decades. This study analyses the top ten trends that will impact the future of the biopharma industry through 2040.

The future of biopharma will be driven by innovation in AI and ML, particularly generative AI, and by advancements in translational medicine and synthetic biology. Futu...

This study charts how digital health ecosystems are likely to form and scale through 2040 and what that implies for providers, payers, technology vendors, and retail/community partners. We define a digital health ecosystem as an interoperable platform that coordinates people, data, and decisions across home, retail, and hospital settings—secured .....

The global smart hospital market is entering a pivotal growth phase, moving beyond pilot deployments into enterprise-wide transformation. Smart hospitals represent a digitally enabled model of care delivery, built on the integration of IoT, interoperability, AI, digital twins, and extended care models such as hospital-at-home and virtual care. In t...

Women’s health is moving beyond single-condition apps and episodic visits toward connected care that follows each life stage—from adolescence to pregnancy and postpartum, through perimenopause and healthy aging. What makes this feasible now is the convergence of policy tailwinds (e.g., expanded postpartum coverage), AI+ at-home diagnostics (ea...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The...

Viral vectors are a critical part of gene therapies and genetic medicines, which are the cornerstone of precision medicines to cure rare diseases, cancers, and genetic disorders. Traditional bioprocessing, however, is tedious, less flexible, batch-based, and heavily manual; as a result, manufacturing processes involve high costs, scalability issues...

Stroke remains the leading cause of long-term disability and mortality worldwide, with every minute of delayed diagnosis resulting in irreversible neuronal damage. Recent advancements in AI-powered imaging and portable diagnostic devices are transforming the stroke diagnosis landscape by enabling rapid, decentralized, and data-driven assessment. Th...

This research service offers a comprehensive analysis of the global genetic testing industry (specifically, germline genetic testing, which analyzes inherited genetic variations present in an individual from birth and can be passed to offspring). The industry growth is driven by a shift towards preventive care, rising maternal ages, increasing go.....